Literature DB >> 25977374

Factors affecting faecal immunochemical test positive rates: demographic, pathological, behavioural and environmental variables.

Erin L Symonds1, Joanne M Osborne2, Stephen R Cole2, Peter A Bampton3, Robert J L Fraser4, Graeme P Young5.   

Abstract

OBJECTIVES: Positive rates in faecal immunochemical test (FIT)-based colorectal cancer screening programmes vary, suggesting that differences between programmes may affect test results. We examined whether demographic, pathological, behavioural, and environmental factors affected haemoglobin concentration and positive rates where samples are mailed.
METHODS: A retrospective cohort study; 34,298 collection devices were sent, over five years, to screening invitees (median age 60.6). Participant demographics, temperature on sample postage day, and previous screening were recorded. Outcomes from colonoscopy performed within a year following FIT were collected. Multivariate logistic regression identified significant predictors of test positivity.
RESULTS: Higher positive rate was independently associated with male gender, older age, lower socioeconomic status, and distally located neoplasia, and negatively associated with previous screening (p < 0.05). Older males had higher faecal haemoglobin concentrations and were less likely to have a false positive result at colonoscopy (p < 0.05). High temperature on the sample postage day was associated with reduced haemoglobin concentration and positivity rate (26-35℃: Odds ratio 0.78, 95% confidence interval 0.66-0.93), but was not associated with missed significant neoplasia at colonoscopy (p > 0.05).
CONCLUSIONS: Haemoglobin concentrations, and therefore FIT positivity, were affected by factors that vary between screening programmes. Participant demographics and high temperature at postage had significant effects. The impact of temperature could be reduced by seasonal scheduling of invitations. The importance of screening, and following up positive test results, particularly in older males, should be promoted.
© The Author(s) 2015.

Entities:  

Keywords:  Colorectal cancer screening; Faecal immunochemical test; Haemoglobin stability; Occult blood; temperature

Mesh:

Substances:

Year:  2015        PMID: 25977374     DOI: 10.1177/0969141315584783

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  22 in total

1.  Low Sensitivity of Fecal Immunochemical Tests (FIT) for Detection of Sessile Serrated Adenomas/Polyps Confirmed Over Clinical Setting, Geography, and FIT System.

Authors:  Craig Mowat; Jayne Digby; Judith A Strachan; Robert J C Steele; Callum G Fraser
Journal:  Dig Dis Sci       Date:  2019-05-18       Impact factor: 3.199

2.  One-Time Fecal Immunochemical Screening for Advanced Colorectal Neoplasia in Patients with CKD (DETECT Study).

Authors:  Germaine Wong; Richard L Hope; Kirsten Howard; Jeremy R Chapman; Antoni Castells; Simon D Roger; Michael J Bourke; Petra Macaskill; Robin Turner; Gabrielle Williams; Wai Hon Lim; Charmaine E Lok; Fritz Diekmann; Nicholas B Cross; Shaundeep Sen; Richard D M Allen; Steven J Chadban; Carol A Pollock; Allison Tong; Armando Teixeira-Pinto; Jean Y H Yang; Narelle Williams; Eric Hoi Kit Au; Anh Kieu; Laura James; Jonathan C Craig
Journal:  J Am Soc Nephrol       Date:  2019-04-30       Impact factor: 10.121

3.  An Exploratory Analysis of Fecal Immunochemical Test Performance for Colorectal Cancer Screening in Nigeria.

Authors:  Gregory C Knapp; Avinash Sharma; Bolatito Olopade; Olusegun I Alatise; Olalekan Olasehinde; Olujide O Arije; Philip E Castle; T Peter Kingham
Journal:  World J Surg       Date:  2019-11       Impact factor: 3.352

4.  Participant-Related Risk Factors for False-Positive and False-Negative Fecal Immunochemical Tests in Colorectal Cancer Screening: Systematic Review and Meta-Analysis.

Authors:  Clasine M de Klerk; Lisanne M Vendrig; Patrick M Bossuyt; Evelien Dekker
Journal:  Am J Gastroenterol       Date:  2018-08-29       Impact factor: 10.864

5.  Low Sensitivity of Fecal Immunochemical Tests and Blood-Based Markers of DNA Hypermethylation for Detection of Sessile Serrated Adenomas/Polyps.

Authors:  Charles Cock; Shahzaib Anwar; Susan E Byrne; Rosie Meng; Susanne Pedersen; Robert J L Fraser; Graeme P Young; Erin L Symonds
Journal:  Dig Dis Sci       Date:  2019-03-05       Impact factor: 3.199

6.  A Comparison of Fecal Immunochemical and High-Sensitivity Guaiac Tests for Colorectal Cancer Screening.

Authors:  Jean A Shapiro; Janet K Bobo; Timothy R Church; Douglas K Rex; Gary Chovnick; Trevor D Thompson; Ann G Zauber; David Lieberman; Theodore R Levin; Djenaba A Joseph; Marion R Nadel
Journal:  Am J Gastroenterol       Date:  2017-10-10       Impact factor: 10.864

7.  Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions.

Authors:  Nielson T Baxter; Mack T Ruffin; Mary A M Rogers; Patrick D Schloss
Journal:  Genome Med       Date:  2016-04-06       Impact factor: 11.117

8.  Predictive Modeling of Colonoscopic Findings in a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program.

Authors:  Jade Law; Anand Rajan; Harry Trieu; John Azizian; Rani Berry; Simon W Beaven; James H Tabibian
Journal:  Dig Dis Sci       Date:  2021-08-04       Impact factor: 3.487

9.  Alternative diagnoses and demographics associated with a raised quantitative faecal immunochemical test in symptomatic patients.

Authors:  Mark S Johnstone; Gillian Miller; Grace Pang; Paul Burton; Georgios Kourounis; Jack Winter; Emilia Crighton; David Mansouri; Paul Witherspoon; Karen Smith; Stephen T McSorley
Journal:  Ann Clin Biochem       Date:  2022-03-03       Impact factor: 2.587

10.  Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?

Authors:  Eunate Arana-Arri; Isabel Idigoras; Begoña Uranga; Raquel Pérez; Ana Irurzun; Iñaki Gutiérrez-Ibarluzea; Callum G Fraser; Isabel Portillo
Journal:  BMC Cancer       Date:  2017-08-29       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.